Metabolic Reprogramming—A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun

Allogeneic hematopoietic stem cell transplantation (HSCT) is the solitary therapeutic therapy for many types of hematological cancers. The benefits of this procedure are challenged by graft vs. host disease (GVHD), causing significant morbidity and mortality. Recent advances in the metabolomics fiel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Reena, Palaniyandi, Senthilnathan, Hildebrandt, Gerhard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748087/
https://www.ncbi.nlm.nih.gov/pubmed/33343357
http://dx.doi.org/10.3389/fphar.2020.588449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748087/
https://www.ncbi.nlm.nih.gov/pubmed/33343357
http://dx.doi.org/10.3389/fphar.2020.588449

Ejemplares similares